318 related articles for article (PubMed ID: 10529127)
41. Improved functional ability in patients with rheumatoid arthritis--longterm treatment with leflunomide versus sulfasalazine. European Leflunomide Study Group.
Kalden JR; Scott DL; Smolen JS; Schattenkirchner M; Rozman B; Williams BD; Kvien TK; Jones P; Williams RB; Oed C; Rosenburg R;
J Rheumatol; 2001 Sep; 28(9):1983-91. PubMed ID: 11550964
[TBL] [Abstract][Full Text] [Related]
42. Slow acting antirheumatic drugs in patients with juvenile rheumatoid arthritis--evaluated in a randomized, parallel 50-week clinical trial.
Kvien TK; Høyeraal HM; Sandstad B
J Rheumatol; 1985 Jun; 12(3):533-9. PubMed ID: 3930720
[TBL] [Abstract][Full Text] [Related]
43. Termination of slow acting antirheumatic therapy in rheumatoid arthritis: a 14-year prospective evaluation of 1017 consecutive starts.
Wolfe F; Hawley DJ; Cathey MA
J Rheumatol; 1990 Aug; 17(8):994-1002. PubMed ID: 1976811
[TBL] [Abstract][Full Text] [Related]
44. Second-line antirheumatic drugs in the elderly with rheumatoid arthritis: a post hoc analysis of three controlled trials.
Dahl SL; Samuelson CO; Williams HJ; Ward JR; Karg M
Pharmacotherapy; 1990; 10(2):79-84. PubMed ID: 2112243
[TBL] [Abstract][Full Text] [Related]
45. Indirect and total costs of early rheumatoid arthritis: a randomized comparison of combined step-down prednisolone, methotrexate, and sulfasalazine with sulfasalazine alone.
Korthals-de Bos I; Van Tulder M; Boers M; Verhoeven AC; Adèr HJ; Bibo J; Boonen A; Van Der Linden S
J Rheumatol; 2004 Sep; 31(9):1709-16. PubMed ID: 15338488
[TBL] [Abstract][Full Text] [Related]
46. Rheumatoid arthritis: limiting the damage.
Hosie G
Nurs Times; 2002 Mar 28-Apr 1; 98(13):34-6. PubMed ID: 11974758
[No Abstract] [Full Text] [Related]
47. Sulfasalazine therapy for psoriatic arthritis: a double blind, placebo controlled trial.
Gupta AK; Grober JS; Hamilton TA; Ellis CN; Siegel MT; Voorhees JJ; McCune WJ
J Rheumatol; 1995 May; 22(5):894-8. PubMed ID: 8587078
[TBL] [Abstract][Full Text] [Related]
48. Factors predicting response to treatment in rheumatoid arthritis: the importance of disease duration.
Anderson JJ; Wells G; Verhoeven AC; Felson DT
Arthritis Rheum; 2000 Jan; 43(1):22-9. PubMed ID: 10643696
[TBL] [Abstract][Full Text] [Related]
49. A randomized, double-blind, multicenter, controlled clinical trial of chicken type II collagen in patients with rheumatoid arthritis.
Zhang LL; Wei W; Xiao F; Xu JH; Bao CD; Ni LQ; Li XF
Arthritis Rheum; 2008 Jul; 59(7):905-10. PubMed ID: 18576295
[TBL] [Abstract][Full Text] [Related]
50. A cost effectiveness analysis of treatment options for methotrexate-naive rheumatoid arthritis.
Choi HK; Seeger JD; Kuntz KM
J Rheumatol; 2002 Jun; 29(6):1156-65. PubMed ID: 12064828
[TBL] [Abstract][Full Text] [Related]
51. How aggressive should initial therapy for rheumatoid arthritis be? Factors associated with response to 'non-aggressive' DMARD treatment and perspective from a 2-yr open label trial.
Matteson EL; Weyand CM; Fulbright JW; Christianson TJ; McClelland RL; Goronzy JJ
Rheumatology (Oxford); 2004 May; 43(5):619-25. PubMed ID: 14983105
[TBL] [Abstract][Full Text] [Related]
52. Efficacy and safety of hydroxychloroquine sulphate in rheumatoid arthritis: a randomized, double-blind, placebo controlled clinical trial--an Indian experience.
Das SK; Pareek A; Mathur DS; Wanchu A; Srivastava R; Agarwal GG; Chauhan RS
Curr Med Res Opin; 2007 Sep; 23(9):2227-34. PubMed ID: 17692155
[TBL] [Abstract][Full Text] [Related]
53. Intravenous human recombinant tumor necrosis factor receptor p55-Fc IgG1 fusion protein Ro 45-2081 (lenercept): a double blind, placebo controlled dose-finding study in rheumatoid arthritis.
Rau R; Sander O; van Riel P; van de Putte L; Hasler F; Zaug M; Kneer J; van der Auwera P; Stevens RM;
J Rheumatol; 2003 Apr; 30(4):680-90. PubMed ID: 12672184
[TBL] [Abstract][Full Text] [Related]
54. Treatment of poor-prognosis early rheumatoid arthritis. A randomized study of treatment with methotrexate, cyclosporin A, and intraarticular corticosteroids compared with sulfasalazine alone.
Proudman SM; Conaghan PG; Richardson C; Griffiths B; Green MJ; McGonagle D; Wakefield RJ; Reece RJ; Miles S; Adebajo A; Gough A; Helliwell P; Martin M; Huston G; Pease C; Veale DJ; Isaacs J; van der Heijde DM; Emery P
Arthritis Rheum; 2000 Aug; 43(8):1809-19. PubMed ID: 10943871
[TBL] [Abstract][Full Text] [Related]
55. Efficacy of tacrolimus in rheumatoid arthritis patients who have been treated unsuccessfully with methotrexate: a six-month, double-blind, randomized, dose-ranging study.
Furst DE; Saag K; Fleischmann MR; Sherrer Y; Block JA; Schnitzer T; Rutstein J; Baldassare A; Kaine J; Calabrese L; Dietz F; Sack M; Senter RG; Wiesenhutter C; Schiff M; Stein CM; Satoi Y; Matsumoto A; Caldwell J; Harris RE; Moreland LW; Hurd E; Yocum D; Stamler DA
Arthritis Rheum; 2002 Aug; 46(8):2020-8. PubMed ID: 12209503
[TBL] [Abstract][Full Text] [Related]
56. Impact of initial aggressive drug treatment with a combination of disease-modifying antirheumatic drugs on the development of work disability in early rheumatoid arthritis: a five-year randomized followup trial.
Puolakka K; Kautiainen H; Möttönen T; Hannonen P; Korpela M; Julkunen H; Luukkainen R; Vuori K; Paimela L; Blåfield H; Hakala M; Leirisalo-Repo M
Arthritis Rheum; 2004 Jan; 50(1):55-62. PubMed ID: 14730599
[TBL] [Abstract][Full Text] [Related]
57. Degree and extent of response to sulphasalazine or penicillamine therapy for rheumatoid arthritis: results from a routine clinical environment over a two-year period.
Capell HA; Marabani M; Madhok R; Torley H; Hunter JA
Q J Med; 1990 Apr; 75(276):335-44. PubMed ID: 1974723
[TBL] [Abstract][Full Text] [Related]
58. The effects of an orally administered probiotic on sulfasalazine metabolism in individuals with rheumatoid arthritis: a preliminary study.
Lee HJ; Waller RD; Stebbings S; Highton J; Orlovich DA; Schmierer D; Fawcett JP
Int J Rheum Dis; 2010 Feb; 13(1):48-54. PubMed ID: 20374384
[TBL] [Abstract][Full Text] [Related]
59. Bone alkaline phosphatase in rheumatoid arthritis: a longitudinal study.
Beyeler C; Banks R; Thompson D; Forbes MA; Cooper EH; Bird HA
J Rheumatol; 1996 Feb; 23(2):241-4. PubMed ID: 8882026
[TBL] [Abstract][Full Text] [Related]
60. "Disease-modifying" drugs in rheumatoid arthritis.
Drug Ther Bull; 1985 Dec; 23(26):101-4. PubMed ID: 2866082
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
